000			01972 a2200589 4500
005			20250513121700.0
264		0	_c19970717
008			199707s 0 0 eng d
022			_a0002-8703
024	7		_a10.1016/s0002-8703(97)70164-9 _2doi
040			_aNLM _beng _cNLM
100	1		_aCaliff, R M
245	0	0	_aSelection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators. _h[electronic resource]
260			_bAmerican heart journal _cJun 1997
300			_a630-9 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aAnticoagulants _xadministration & dosage
650	0	4	_aBlood Pressure
650	0	4	_aFibrinolytic Agents _xadministration & dosage
650	0	4	_aForecasting
650	0	4	_aHeart Rate
650	0	4	_aHeparin _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aInjections, Intravenous
650	0	4	_aInjections, Subcutaneous
650	0	4	_aLogistic Models
650	0	4	_aMiddle Aged
650	0	4	_aModels, Statistical
650	0	4	_aMyocardial Infarction _xdrug therapy
650	0	4	_aPlasminogen Activators _xadministration & dosage
650	0	4	_aPrognosis
650	0	4	_aRisk Factors
650	0	4	_aStreptokinase _xadministration & dosage
650	0	4	_aSurvival Rate
650	0	4	_aThrombolytic Therapy
650	0	4	_aTissue Plasminogen Activator _xadministration & dosage
650	0	4	_aTreatment Outcome
700	1		_aWoodlief, L H
700	1		_aHarrell, F E
700	1		_aLee, K L
700	1		_aWhite, H D
700	1		_aGuerci, A
700	1		_aBarbash, G I
700	1		_aSimes, R J
700	1		_aWeaver, W D
700	1		_aSimoons, M L
700	1		_aTopol, E J
773	0		_tAmerican heart journal _gvol. 133 _gno. 6 _gp. 630-9
856	4	0	_uhttps://doi.org/10.1016/s0002-8703(97)70164-9 _zAvailable from publisher's website
999			_c9180904 _d9180904